STAT

MAY 1, 2024

Doing so creates an incredibly rich database of information about the human brain for scientists to query in order to uncover how our brains work when we are healthy and go awry when we are sick. Findings from ongoing LBP studies are collectively anticipated to make key advances in our understanding of human brain biology.

Hospitals 104

Hospitals 104

STAT

APRIL 22, 2024

But when an unexpected announcement from the chief executive titled “A message about our future” popped into inboxes one morning last month, that frustration seemed to fully ignite. ” Continue to STAT+ to read the full story… Discontent among Mass General Brigham doctors had been at a slow burn for years.

Hospitals 143

Hospitals Patient Care 143

NF2 BioSolutions

MARCH 25, 2024

That’s where our ‘Understanding NF2’ podcast steps in. From the latest research and treatment options to personal stories of resilience and courage, the podcast offers a comprehensive look at the disease. Our mission is to foster a better understanding of NF2 and create a supportive community for those affected.

69

69

STAT

JANUARY 10, 2024

launched its 100,000 Genomes Project, a major research endeavor that involved sequencing the DNA of that many people to discover how our genes shape our health. But the initiative wasn’t just focused on sequencing our regular DNA. Continue to STAT+ to read the full story…

Patient Care 139

Patient Care 139

STAT

DECEMBER 29, 2023

Below is our annual list of stories that STAT staffers loved, and wish that they had written. Also check out the jealousy list from Bloomberg Businessweek, which had the idea first.) Read the rest…

Insurance 145

Insurance 145

STAT

APRIL 2, 2024

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. Continue to STAT+ to read the full story… A Phase 1 study is expected to read out toward the middle of the year.

121

121

STAT

NOVEMBER 17, 2023

“We partnered closely with leading experts in our clinical community who could help us in our journey to get this technology to the people who need it most.” ” Continue to STAT+ to read the full story…

FDA 140

FDA 140

STAT

JANUARY 4, 2024

“Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

137

137

STAT

APRIL 19, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

112

112

STAT

OCTOBER 23, 2023

“Our study is called HEART-1 and our plan now is to activate U.S. ” Continue to STAT+ to read the full story… Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

FDA 144

FDA 144

STAT

DECEMBER 7, 2023

“We continue to advance our organic efforts and we remain committed to bringing a patch pump to market that integrates our most advanced CGM platform and clinically proven Meal Detection Technology algorithm,” Janet Cho, a Medtronic spokesperson, wrote to STAT. Continue to STAT+ to read the full story…

136

136

STAT

MARCH 25, 2024

We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.” ” Continue to STAT+ to read the full story…

FDA 139

FDA 139

STAT

APRIL 26, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…  That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

101

101

STAT

FEBRUARY 22, 2024

Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissions, and inpatient dialysis at our hospitals.” Continue to STAT+ to read the full story…

Hospitals 139

Hospitals Documentation 139

STAT

APRIL 26, 2024

This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is likely to be low key. We plan to manicure the Pharmalot grounds, promenade with the official mascots, and catch up on our napping. Continue to STAT+ to read the full story… Not a moment too soon, yes?

Specialty Pharmacies 126

Specialty Pharmacies Hospitals 126

STAT

APRIL 25, 2024

  Sign up  to get our biotech newsletter in your inbox. Continue to STAT+ to read the full story… Want to stay on top of the science and politics driving biotech today?  Good morning. Well, one option is — you do it yourself.

Hospitals 112

Hospitals 112

STAT

APRIL 24, 2024

Equity and inclusion To achieve true equity in medical science “requires us to divest our research from the ivory towers of elite institutions,” said 2023 honoree Jonathan Jackson , executive director of Community Access, Recruitment, and Engagement Research Center at Massachusetts General Hospital and Harvard Medical School.

Medical Schools 129

Medical Schools Hospitals 129

STAT

MARCH 22, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

116

116

STAT

DECEMBER 21, 2023

It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry. And can you go to too many J.P. Morgan parties?

127

127

STAT

JANUARY 18, 2024

Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

FDA 116

FDA 116

STAT

OCTOBER 10, 2023

My sister has a fantasy about our old age: She imagines that the seven siblings in our family will be living together again, in a house somewhere. Continue to STAT+ to read the full story… Five will be wandering around in bathrobes, lost to dementia. The other two, their minds intact, will look after the lost ones.

124

124

STAT

FEBRUARY 28, 2024

He will “just convey what our experience has been at Cost Plus and, if they ask, [make] suggestions on what we think can make things better,” he told us when asked about his expectations for the meeting. Continue to STAT+ to read the full story…

Insurance 145

Insurance 145

STAT

MAY 2, 2024

Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny, nonetheless. Our choice today is pistachio creme. Continue to STAT+ to read the full story… We recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.”

Insurance 107

Insurance 107

STAT

DECEMBER 21, 2023

But at the center of all these stories are the people they impact: scientists, doctors, patients, and families. Below are our favorite visual moments of 2023, from STAT’s incredible contributing photographers. Read the rest…

140

140

STAT

MARCH 29, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

108

108

STAT

JANUARY 26, 2024

“​​The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement. Continue to STAT+ to read the full story…

136

136

STAT

APRIL 5, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

103

103

STAT

NOVEMBER 14, 2023

For more than a year, our reporters have documented how the use of artificial intelligence is driving denial of claims or delaying treatment for seriously ill patients. This latest story goes even deeper, establishing how the denial of claims was by design.

Health Insurance Companies 132

Health Insurance Companies Documentation Insurance 132

STAT

MARCH 8, 2024

“This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a somber Justin Klee, Amylyx’s co-founder and co-CEO, in an interview with STAT on Thursday evening.

FDA 145

FDA 145

STAT

APRIL 25, 2024

Last night, we held our 2024 STATUS List dinner, honoring  50 influential people shaping the future of health, medicine and life sciences. As always, send feedback and questions to  BiotechScorecard@statnews.com Continue to STAT+ to read the full story…

103

103

STAT

DECEMBER 13, 2023

Sign up for our Morning Rounds newsletter here. Don’t miss Brittany Trang’s compelling story about seven-year-old Shelby Campbell’s life — and her family’s — while being treated for beta thalassemia with gene therapy. Good morning.

Hospitals 98

Hospitals 98

STAT

APRIL 19, 2024

This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape. However, we do foresee several naps in our future, if only to recover from promenading with the official mascots. We also hope to catch up on our reading and hold another listening party with Mrs. Pharmalot.

114

114

STAT

DECEMBER 14, 2023

“The steps we are announcing today reflect our conviction that the rapid convergence of ‘biotech’ and ‘tech’ will unlock the next frontier of innovation in biotechnology.” ” Continue to STAT+ to read the full story…

136

136

STAT

MARCH 15, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them.  Don’t  Don’t be shy. Everyone wants to know who is coming and going.

104

104

STAT

OCTOBER 4, 2023

  Sign up  to get our biotech newsletter in your inbox. Damian here with the precarious case of gene therapy in Europe, a long-awaited coup for Novavax, and the unwinding of Amgen’s success story. Want to stay on top of the science and politics driving biotech today?  Good morning, everyone.

Vaccines 111

Vaccines FDA 111

STAT

APRIL 12, 2024

And here is our regular feature in which we highlight a different person each week. Continue to STAT+ to read the full story…   That’s right. Send  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

99

99

STAT

APRIL 24, 2024

  Sign up  to get our biotech newsletter in your inbox. Continue to STAT+ to read the full story… Want to stay on top of the science and politics driving biotech today?  Good morning! But then several months later, it decided to discontinue one of those products, the basal insulin Levemir.

123

123